SCHEMBL249604

SCHEMBL249604

CCN1[CH]CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6506979 0.97
SCHEMBL249356 0.92
SCHEMBL607241 0.80
SCHEMBL689547 0.77
SCHEMBL2099498 0.77 CYP1A2 (0.34)
SCHEMBL6506199 0.75 L3MBTL1 (0.33)
SCHEMBL1168662 0.75 LTA4H (0.35)
SCHEMBL2106033 0.73 LTA4H (0.38)
SCHEMBL6506570 0.73 L3MBTL1 (0.36)
SCHEMBL2099984 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 515 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208935-A1 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2024-06-27 US claimed
CN-118125997-A Pterocarpus stilbene paeonol chalcone amide derivative, preparation method and medical application thereof 安徽中医药大学 2024-06-04 CN claimed
EP-4326712-A1 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES The Regents of The University of California (US) 2024-02-28 EP claimed
CN-116854649-A Gemini quaternary ammonium base type structure directing agent, preparation method thereof, AFX molecular sieve, preparation method thereof and application thereof 华东理工大学 2023-10-10 CN claimed
WO-2023186171-A1 CATIONIC LIPID, LIPOSOME, LIPID NANOPARTICLE, AND USE 科镁信(上海)生物医药科技有限公司 2023-10-05 WO claimed
WO-2022226172-A1 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-10-27 WO claimed
US-10829466-B2 Stilbene derivative and preparation method thereof BEIJING INSTITUTE OF TECHNOLOGY (CN) 2020-11-10 US claimed
US-20200148662-A1 NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF BEIJING INSTITUTE OF TECHNOLOGY (CN) 2020-05-14 US claimed
US-20190275046-A1 NOVEL COMBINATION INTRA-CELLULAR THERAPIES, INC. (US) 2019-09-12 US claimed
US-20190192519-A1 NOVEL USES INTRA-CELLULAR THERAPIES, INC. (US) 2019-06-27 US claimed
US-20050222135-A1 Active substance combination LABORATIONS DEL DR. ESTEVE S.A. (ES) 2005-10-06 US claimed
EP-1416933-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR Amgem, Inc. (US) 2004-05-12 EP claimed
WO-2003009847-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEM, INC. (US) 2003-02-06 WO claimed
US-5705497-A INOTROPIC, ANTIARRHYTHMIA AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1998-01-06 US claimed
US-5367062-A Disubstituted and deoxydisubstituted derivatives of α-d-lyxofuranosides having anti-inflammatory and anti-proliferative activity MEDICARB INC. (US) 1994-11-22 US claimed
US-RE33907-E Anti-spasmodic agents having a heterocyclic ring UNITED PHARMACEUTICALS, INC. (US) 1992-04-28 US claimed
US-4857535-A THIOESTERS UNITED PHARMACEUTICALS (US) 1989-08-15 US claimed
US-4721783-A SMOOTH MUSCLES UNITED PHARMACEUTICALS, INC. (US) 1988-01-26 US claimed
US-4456755-A ANTIBIOTICS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1984-06-26 US claimed
US-4419444-A AGGLUTINATION INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE-INSERM (FR) 1983-12-06 US claimed